Limitations

\label{limitations}
We have not conducted controlled evaluations for separate insights on the individual visual analytics features described in the Application section.
While the data are limited, we plan to get data permissions to add many times as many studies and multiple new assays. Investigators have expressed that each new dataset increases the value of every other. Dimensions such as subject demographics and adverse events that may point to vaccine safety issues are also in our development backlog. Still, eight out of 10 target users (and all non-target users) reported the data already in the system were personally valuable.
The results are encouraging but the true test of value is scientific impact on papers, studies, and collaborations, which we plan to measure over time through personal follow-up on automatic usage cues.